Generate a tailored SOP for Dr. Aude Chapuis. Improve your application with a focused, well-structured draft.
Aude Chapuis is an Associate Professor at Fred Hutchinson Cancer Research Center in the Translational Science Therapeutics Division. She is a leading expert in blood stem cell transplantation and immunotherapy, focusing on the development of new immunotherapies that utilize T cells to detect and destroy diseased cells. Dr. Chapuis' research laboratory investigates factors that make T cell therapy successful and uses this knowledge to develop safer and more effective immunotherapies. Her ongoing projects include advancing T cell therapies for patients with leukemias and solid tumors, including melanoma and Merkel cell carcinoma. Dr. Chapuis also collaborates on clinical trials aimed at enhancing T cell function and developing TCR-engineered therapies targeting specific antigens in cancer treatments. She has played an instrumental role in the optimization of clinically applicable methods for TCR gene transfer to T cells, particularly focusing on antigens commonly expressed in myeloid leukemias. Dr. Chapuis' clinical expertise includes managing patients undergoing autologous and allogeneic transplants, as well as overseeing immunotherapy trials. Her dedication and innovative approach continue to drive advancements in cancer treatment and patient care.
Fred Hutchinson Cancer Research Center • Seattle, WA
Associate Professor in the Translational Science Therapeutics Division, focusing on immunotherapy and T cell research.
Fred Hutchinson Cancer Research Center • Seattle, WA
Provides clinical care to patients undergoing stem cell transplantation and immunotherapy.
Fred Hutch provides training for many UW-affiliated PhD programs. This entry covers the interdisciplinary Molecular and Cellular Biology (MCB) program which encompasses departments like Biology, Medicine, and Human Biology.